Firefly Neuroscience And Next Health Partner To Launch Precision Cognitive Health Platform Integrating Firefly’s AI-Powered, FDA-Cleared EEG/ERP Brain Biomarker Technology With Personalized Cognitive Peptide Protocols
– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week – – These two peptides have attracted growing scientific interest for their
Firefly Neuroscience and Next Health are teaming up to help people understand and improve their brain health using special brain scans and personalized medicine. This shows the company is finding real partners who believe in its brain technology, which is a good sign for its business growth.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.